Inflammatory Bowel Diseases and Non-Alcoholic Fatty Liver Disease: Piecing a Complex Puzzle Together

R Maresca, I Mignini, S Varca, V Calvez… - International Journal of …, 2024 - mdpi.com
Inflammatory bowel diseases (IBD), comprising Crohn's disease and ulcerative colitis, are
systemic and multifaceted disorders which affect other organs in addition to the …

Liver fibrosis with methotrexate—an overestimated risk?

RJ Andrade, ES Björnsson - Nature Reviews Gastroenterology & …, 2023 - nature.com
A prospective study suggests that the risk of liver fibrosis with methotrexate treatment has
been overestimated. The findings suggest the need to reconsider the intensive strategies …

USP40 promotes hepatocellular carcinoma progression through a YAP/USP40 positive feedback loop

H Mo, R Li, N Yang, J Han, X Xiao, Y Zhang, Z Xiao… - Cancer Letters, 2024 - Elsevier
Yes-associated protein (YAP) is an essential driver of hepatocellular carcinoma (HCC)
progression and the ubiquitin-proteasome system controls its abundance. However, the role …

Hepatic Stellate Cell‐Targeting Micelle Nanomedicine for Early Diagnosis and Treatment of Liver Fibrosis

L Wang, J Zhou, J Wang, X Wang… - Advanced …, 2024 - Wiley Online Library
Diagnosing and treating liver fibrosis is a challenging yet crucial endeavor due to its
complex pathogenesis and risk of deteriorating into cirrhosis, liver failure, and even hepatic …

Protective role of Cecropin AD against LPS-induced intestinal mucosal injury in chickens

Y Zhi, T Li, Y Li, T Zhang, M Du, Q Zhang… - Frontiers in …, 2023 - frontiersin.org
Introduction Cecropin AD (CAD), a renowned antimicrobial peptide, has shown promising
potential in treating various bacterial infections. This study investigates the protective effects …

Methotrexate-induced liver fibrosis: The end of a long-held belief

V Di Martino - Journal of Hepatology, 2023 - journal-of-hepatology.eu
Editorial compared with risk factors for chronic liver disease. Ironically, the proportion of
patients with cirrhosis was higher in methotrexate-naive patients, who had higher alcohol …

Benzoylaconitine alleviates progression of psoriasis via suppressing STAT3 phosphorylation in keratinocytes

Y Li, D Guo, Q Wang, A Li, S Yin, S Li, Y Li, B Wang… - Molecules, 2023 - mdpi.com
Psoriasis is a chronic and multifactorial skin disease which is caused by inflammatory
infiltrates, keratinocyte hyperproliferation, and accumulation of immune cells. As part of the …

Cumulative methotrexate dose is not associated with liver fibrosis in patients with a history of moderate-to-severe psoriasis

P Babakinejad, R Lapsley, L Forster… - British Journal of …, 2024 - academic.oup.com
Background There are established risk factors for liver fibrosis (LF), but data on the impact of
methotrexate on LF in patients with psoriasis are lacking. Objectives This cross-sectional …

Associated factors with liver fibrosis in rheumatoid arthritis patients treated with methotrexate

M Slouma, W Lahmar, G Mohamed, O Dhrif… - Clinical …, 2024 - Springer
Introduction There are conflicting findings on the link between liver fibrosis and cumulative
methotrexate dosages. We aimed to determine the frequency of liver fibrosis in rheumatoid …

[HTML][HTML] Применение метотрексата при ревматоидном артрите. Рекомендации Общероссийской общественной организации «Ассоциация ревматологов …

ЕЛ Насонов, ВН Амирджанова… - Научно …, 2023 - cyberleninka.ru
Ревматоидный артрит (РА)-наиболее частое иммуновоспалительное (аутоиммунное)
ревматическое заболевание, характеризующееся хроническим эрозивным артритом и …